Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
ESSA Pharma Inc. (EPIX) had Normalized Pre-Tax Income of $-26.58M for the most recently reported fiscal year, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-26.58M |
|
-- |
|
-- |
|
$32.14M |
|
$-32.14M |
|
$5.56M |
|
$-26.58M |
|
|
Normalized Pre-Tax Income |
$-26.58M |
$-26.58M |
|
$-26.58M |
|
$-26.58M |
|
$-26.58M |
|
$-32.14M |
|
$-32.02M |
|
44.09M |
|
44.09M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$148.80M |
|
-- |
|
$0.33M |
|
$149.12M |
|
$3.50M |
|
-- |
|
-- |
|
$3.50M |
|
$145.63M |
|
$145.63M |
|
$145.63M |
|
44.10M |
|
| Cash Flow Statement Financials | |
$-19.78M |
|
$-3.53M |
|
$-0.07M |
|
$57.08M |
|
$33.70M |
|
$-23.37M |
|
$5.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
42.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.25% |
|
-18.25% |
|
-17.83% |
|
-18.25% |
|
$3.30 |
|
$-0.45 |
|
$-0.45 |
|